Novanta Inc. - Common Shares (NOVT)

Record margins and medical momentum stand out, but a U.K. plant slowdown adds a clear headwind.

Novanta (NASDAQ:NOVT) reported third-quarter revenue growth of 23% and its strongest organic growth in more than three years, as demand for robotics and advanced manufacturing products helped offset weakness in precision medicine. The company also completed its largest acquisition, Riverpoint Medica

Medicine and manufacturing technology provider Novanta (NASDAQ:NOVT) announced better-than-expected revenue in Q3 2026, with revenue up 23.1% year on year to...

Medicine and manufacturing technology provider Novanta (NASDAQ:NOVT) will be reporting results this Monday afternoon. Here’s what to expect. Novanta beat ana...

Novanta has been treading water for the past six months, recording a small return of 4.1% while holding steady at $138.70. Given the underwhelming price acti...

Companies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments. Some lack leverage because they strugg...

What Happened? A number of stocks fell in the afternoon session after explosions reported in the Saudi capital and escalating clashes near critical maritime ...

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these f...

Whether you see them or not, industrials businesses play a crucial part in our daily activities. But they are at the whim of volatile macroeconomic factors t...

What Happened? A number of stocks jumped in the morning session after weaker-than-expected U.S. employment data cooled Treasury yields, easing borrowing-cost...

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifi...

“You get what you pay for” often applies to expensive stocks with best-in-class business models and execution. While their quality can sometimes justify the ...

Novanta (NASDAQ:NOVT) has outperformed the market over the past 15 years by 7.74% on an annualized basis producing an average annual return of 21.09%. Currently, Novanta has a market capitalization of $5.28 billion.

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...

The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how electronic components ...

Novanta (NASDAQ:NOVT) has outperformed the market over the past 10 years by 10.52% on an annualized basis producing an average annual return of 23.93%. Currently, Novanta has a market capitalization of $5.17 billion.

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that ...

Novanta (NASDAQ:NOVT) has outperformed the market over the past 15 years by 7.55% on an annualized basis producing an average annual return of 21.3%. Currently, Novanta has a market capitalization of $5.97 billion.

Organic growth hit a three-year high as AI and robotics demand accelerated.

Novanta's second quarter was marked by broad-based organic growth across all business units and a favorable response from the market. Management attributed t...

Novanta (NASDAQ:NOVT) reported second-quarter results marked by 9% organic sales growth, expanding margins and higher operating cash flow, while raising its full-year outlook following the late-July closing of its Riverpoint Medical acquisition. Chair and Chief Executive Officer Matthijs Glastra sa

Medicine and manufacturing technology provider Novanta (NASDAQ:NOVT) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 10.3% year on year t...

Medicine and manufacturing technology provider Novanta (NASDAQ:NOVT) announced better-than-expected revenue in Q2 CY2026, with sales up 10.3% year on year to...

Medicine and manufacturing technology provider Novanta (NASDAQ:NOVT) will be reporting earnings this Wednesday after market hours. Here’s what to look for. N...